Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

45.6K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Course and clinical outcomes of chronic hepatitis delta: a longitudinal analysis of 565 patients from the D-SOLVE and HDV-1000 consortia.

Gut·2026
Same author

B-BEST: Profiling the intrahepatic HBV reservoir at single-cell resolution.

Hepatology (Baltimore, Md.)·2026
Same author

Hepatitis D Virus: Enigmas and Gaps of Knowledge.

Viruses·2026
Same author

Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps.

Vaccines·2026
Same author

Adenine Base Editing Potently Suppresses Hepatitis B Surface Antigen Expression and Inhibits Hepatitis D Virus Release.

bioRxiv : the preprint server for biology·2026
Same author

HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER).

Gut·2025

Related Experiment Video

Updated: May 28, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.1K

Opportunities and challenges for hepatitis B cure.

Armando Andres Roca Suarez1,2,3, Fabien Zoulim1,2,3,4

  • 1INSERM U1052, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France.

Egastroenterology
|February 13, 2025
PubMed
Summary

Despite available vaccines, chronic hepatitis B virus (HBV) infection affects millions globally. New insights into HBV biology and immune responses are driving the development of novel curative strategies and drug combinations.

Keywords:
Hepatitis, Viral, Human

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.1K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.1K

Related Experiment Videos

Last Updated: May 28, 2025

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.1K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.1K
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

13.1K

Area of Science:

  • Hepatology
  • Virology
  • Immunology

Background:

  • Chronic hepatitis B virus (HBV) infection remains a significant global health issue, with 296 million infected individuals and 820,000 annual deaths.
  • Despite effective vaccines, HBV persistence poses challenges to achieving a cure due to unique viral replication mechanisms.
  • Recent advancements in understanding HBV biology and host immune responses have identified new therapeutic targets.

Purpose of the Study:

  • To review the biological and clinical challenges of chronic HBV infection.
  • To summarize lessons learned from preclinical and clinical evaluations of anti-HBV compounds.
  • To highlight emerging directions in the development of curative HBV therapies.

Main Methods:

  • Literature review of biological and clinical challenges in chronic HBV infection.
  • Analysis of past preclinical and clinical trial data for HBV therapeutics.
  • Synthesis of current research on novel drug targets and combination strategies.

Main Results:

  • Chronic HBV infection presents complex biological hurdles to viral clearance.
  • Past drug development efforts have provided valuable insights into effective evaluation strategies.
  • New understanding of HBV pathogenesis is paving the way for innovative treatment approaches.

Conclusions:

  • Achieving a functional cure for chronic HBV infection requires addressing viral persistence and host immunity.
  • Continued research into novel drug targets and combination therapies is crucial for advancing HBV treatment.
  • Lessons learned from previous studies are guiding the development of more effective curative strategies.